Thyroid Cancer, Papillary: all 178 studies

Page 1 of 2. Open to participants first (54), then studies with results posted, then the rest; newest registration first within each.

• Bethesda Classification and Risk Stratification in Differentiated Thyroid CarcinomaNot yet recruitingNCT07858097
• Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University HospitalsNot yet recruitingNCT07823439
• Clinical Utility of Preoperative Thyroid GuidePx® TestingNot yet recruitingNCT07584447
• Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer SurvivorsRecruitingNCT07545837Not applicable
• Decision Aid Efficacy in Low Risk Thyroid CancerNot yet recruitingNCT07536412Not applicable
• Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA TrialNot yet recruitingNCT07529080Not applicable
• Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)Not yet recruitingNCT07521670Phase 2
• DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.RecruitingNCT07440290Phase 2/3
• Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot StudyRecruitingNCT07376837Not applicable
• Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced UltrasoundRecruitingNCT07357571
• Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer SurgeryNot yet recruitingNCT07354698Phase 4
• Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid CarcinomaRecruitingNCT07302672Not applicable
• Multimodal Deep Learning for Lymph Node Metastasis in Thyroid CancerNot yet recruitingNCT07299318
• Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid CancersRecruitingNCT07140757
• RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid CancerNot yet recruitingNCT07042984
• Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.Not yet recruitingNCT06971965Not applicable
• XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid CancerRecruitingNCT06959641Phase 2
• Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"Not yet recruitingNCT06901908
• The Role of Prophylactic Central Compartment Neck Dissection in the Management of 2 to 4 cm Papillary Thyroid CarcinomaNot yet recruitingNCT06899347Not applicable
• Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid CancerNot yet recruitingNCT06804863Not applicable
• A Study of Online Follow-up in Patients with Papillary Thyroid CancerRecruitingNCT06800482Not applicable
• A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.RecruitingNCT06791005Phase 3
• Ultrasound-guided Thermal Ablation for Papillary Thyroid CarcinomaRecruitingNCT06733740
• Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid CancerNot yet recruitingNCT06730893Not applicable
• Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)RecruitingNCT06730321
• Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid CarcinomaNot yet recruitingNCT06725628
• Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid CarcinomaRecruitingNCT06725576
• Iodine Status and Characteristics of Papillary Thyroid CancerNot yet recruitingNCT06626581
• Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTCRecruitingNCT06623578Not applicable
• Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTCRecruitingNCT06592755
• Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of PatientsRecruitingNCT06468696Not applicable
• Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E MutationRecruitingNCT06440850Phase 2
• The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid CarcinomaRecruitingNCT06316895
• Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New ScaleRecruitingNCT06286631
• Active Surveillance for Low-risk Papillary Thyroid CarcinomaEnrolling by invitationNCT06261190
• Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid SurgeryRecruitingNCT06254859
• AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid CarcinomaRecruitingNCT06241092
• Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical SamplesRecruitingNCT06133374
• Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid CarcinomaRecruitingNCT06087068Phase 2
• A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid CancerRecruitingNCT06082180Phase 3
• Effects of Radioactive Iodine on the Immune System in Thyroid CancerNot yet recruitingNCT05989555
• A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid CarcinomaRecruitingNCT05962892
• Cross-sectional Case and Control Study on Quality of Life, Appearance and Functions in PTC Via Different Surgical ApproachRecruitingNCT05932121
• DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.RecruitingNCT05768178Phase 2/3
• Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAYRecruitingNCT05766098
• A Study of TY-1091 in Patients With Advanced Solid TumorsRecruitingNCT05675605Phase 1/2
• Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCRecruitingNCT05668962Phase 2
• A Clinical Study of Transaxillary Endoscopic and Open Thyroidectomy for PTCRecruitingNCT05545852Not applicable
• Targeted Therapy to Increase RAI Uptake in Metastatic DTCRecruitingNCT05024929
• Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid CarcinomaRecruitingNCT04354324Not applicable
• the Dissection of Lymph Node Posterior to Right Recurrent Laryngeal Nerve for Papillary Thyroid CarcinomaNot yet recruitingNCT03813706Not applicable
• Central Cervical Dissection for Clinical Node Negative Papillary Thyroid CarcinomaNot yet recruitingNCT03813173Not applicable
• Proteomics of Papillary Thyroid CarcinomaRecruitingNCT02814032
• Studies on Tumors of the ThyroidRecruitingNCT00001160
• Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsTerminatedNCT04985604Phase 2Results posted
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsTerminatedNCT04644315Phase 2Results posted
• Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid CancersCompletedNCT04462471Phase 1Results posted
• Treatment of Papillary Thyroid Carcinoma With Radiofrequency AblationCompletedNCT04129411Not applicableResults posted
• Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid CancerActive, not recruitingNCT03914300Phase 2Results posted
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsActive, not recruitingNCT03899792Phase 1/2Results posted
• Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY TrialTerminatedNCT03753919Phase 2Results posted
• A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted TherapyActive, not recruitingNCT03690388Phase 3Results posted
• Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid CancerTerminatedNCT03630120Phase 2Results posted
• Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid CancerTerminatedNCT03506048Phase 2Results posted
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Active, not recruitingNCT03157128Phase 1/2Results posted
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsCompletedNCT03037385Phase 1/2Results posted
• Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)CompletedNCT02973997Phase 2Results posted
• Comparison Between the Axillary Bilateral-breast Approach (ABBA) and Bilateral Axillo-breast Approach (BABA) for Robotic ThyroidectomyCompletedNCT02768753Not applicableResults posted
• Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid CancerTerminatedNCT02408887Phase 2Results posted
• Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid CancerCompletedNCT02393690Phase 2Results posted
• Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid CancerActive, not recruitingNCT02152995Phase 2Results posted
• Central Neck Dissection in Patients With Clinical Node Negative Thyroid CancerCompletedNCT02138214Phase 2Results posted
• Percutaneous Ethanol Injection for Primary Papillary Thyroid MicrocarcinomaTerminatedNCT01974284Not applicableResults posted
• Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary StudyCompletedNCT01927887Not applicableResults posted
• Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid CancerCompletedNCT01811212Phase 2Results posted
• Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid CancerCompletedNCT01723202Phase 2Results posted
• Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436CompletedNCT01534897Not applicableResults posted
• Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid CancerCompletedNCT01502410Phase 2Results posted
• A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 MutationCompletedNCT01286753Phase 2Results posted
• Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid CancerCompletedNCT01208051Phase 1/2Results posted
• Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine TherapyCompletedNCT00729157Phase 2Results posted
• Sutent Adjunctive Treatment of Differentiated Thyroid CancerCompletedNCT00668811Phase 2Results posted
• Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive IodineCompletedNCT00559949Phase 2Results posted
• Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerCompletedNCT00519896Phase 2Results posted
• Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryCompletedNCT00381641Phase 2Results posted
• Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid CancerCompletedNCT00134043Phase 2Results posted
• Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid CancerCompletedNCT00118248Phase 2Results posted
• Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine TherapyCompletedNCT00104871Phase 2Results posted
• Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive IodineCompletedNCT00098813Phase 2Results posted
• Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131CompletedNCT00085293Phase 2Results posted
• Clinicopathological Predictors of Recurrence in Papillary Thyroid CarcinomaCompletedNCT07695974
• Frozen Section-Guided Selective Ipsilateral Central Neck Dissection in Bethesda V-VI Thyroid NodulesCompletedNCT07659717
• Incidental Thyroid Cancer in Cases With Inflammatory Thyroid LesionCompletedNCT07652450Not applicable
• Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid CarcinomaCompletedNCT07391514
• Intraoperative Pathologic Evaluation of Central Lymph Nodes in Papillary Thyroid CarcinomaCompletedNCT07066644
• Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin LevelActive, not recruitingNCT07062211
• More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is EvaluatedCompletedNCT06439745
• Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological ImagesCompletedNCT06399159
• Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid MicrocarcinomaCompletedNCT06325787Not applicable
• a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESSActive, not recruitingNCT06271044Not applicable

← Thyroid Cancer, Papillary overview